Koers Northwest Biotherapeutics, Inc OTC Bulletin Board
Aandelen
US66737P5017
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
|
Omzet 2022 | 1,68 mln. 1,58 mln. | Omzet 2023 | 1,93 mln. 1,81 mln. | Marktkapitalisatie | 822 mln. 769 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -105 mln. -98,28 mln. | Nettowinst (verlies) 2023 | -62 mln. -58,03 mln. | EV/omzet 2022 | 505 x |
Nettoschuld 2022 | 19,29 mln. 18,05 mln. | Nettoschuld 2023 | 43,43 mln. 40,65 mln. | EV/omzet 2023 | 448 x |
K/w-verhouding 2022 |
-7,59
x | K/w-verhouding 2023 |
-11,7
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 90,84% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Linda Powers
CEO | Chief Executive Officer | 68 | 17-05-07 |
Alton Boynton
FOU | Founder | 79 | 18-03-96 |
Marnix Bosch
CTO | Chief Tech/Sci/R&D Officer | 65 | 01-01-00 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Alton Boynton
FOU | Founder | 79 | 18-03-96 |
Linda Powers
CEO | Chief Executive Officer | 68 | 17-05-07 |
Navid Malik
BRD | Director/Board Member | 55 | 01-04-12 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+16,87% | 122 mld. | |
+22,09% | 116 mld. | |
+22,18% | 27,03 mld. | |
-21,30% | 20,36 mld. | |
-16,89% | 16,43 mld. | |
-18,31% | 15,91 mld. | |
-44,74% | 15,6 mld. | |
+62,28% | 14,94 mld. | |
+3,14% | 13,59 mld. |
- Beurs
- Aandelen
- Koers NWBO
- Koers